5-HT Receptors: Subtypes and Second Messengers

References

• Ananth U. S., Leli U., Hauser G. Stimulation of phosphoinositide hydrolysis by serotonin in C6 glioma cells. J. Neurochem 1987; 48: 253–261
   PubMedGoogle Scholar
• Andrade R., Malenka R. C., Nicoll R. A. A G protein couples serotonin and GABAB receptors to the same channels in hippocampus. Science 1986; 234: 1261–1265
   PubMed Web of Science ®Google Scholar
• Barnes N. M., Costall B., Naylor R. J. [3H] Zacopride: Ligand for the identification of 5-HT3 recognition sites. J. Pharm. Pharmacol. 1938; 40: 548–551
   Google Scholar
• Barnes J. M., Barnes N. M., Costall B., Naylor R. J., Tyers M. B. 5-HT3 receptors mediate inhibition of acetylcholine release in cortical tissue. Nature 1989; 338: 762–763
   PubMed Web of Science ®Google Scholar
• Beck S. G., Clarke W. P., Goldfarb J. Spiperone differentiates multiple 5-hydroxytryptamine respoases in rat hippocampal slices in vitro. Eur. J. Pharmacol. 1985; 116: 195–197
   PubMedGoogle Scholar
• Blandina P., Goldfarb J., Green J. P. Activation of 5-HT3 receptor releases dopamine from ratstriatal slice. Eur. J Pharmacol. 1988; 155: 349–350
   PubMedGoogle Scholar
• Bockaert J., Dumuis A., Bouhelal R., Sebben M., Cory R. N. Piperazine derivatives including the putative anxiolytic drugs, buspirone and ipsapirone, are agonists at 5-HT1A receptors negatively coupled with adenylate cyclase in hippocampal neurons. Naunyn-Schmiedeberg's Arch. Pharmacol. 1987; 335: 588–592
   Google Scholar
• Bockaert J., Nelson D. L., Herbet A., Adrien J., Enjalbert A., Hamon M. Serotonin receptors coupled with an adenylate cyclase in the rat brain: non identity with [3H]-5-HT binding sites. Advances in Experimental Medicine and Biology, Haber, Gabay, Issidorides, Alivisatos, 1981; 133: 327–345
   Google Scholar
• Bouhelal R., Smounya L., Bockaert J. 5-HT1B receptors are negatively coupled with adenylate cyclase in rat substantia nigra. Eur. J. Pharmacol. 1988; 151: 189–196
   PubMedGoogle Scholar
• Bradley P. B., Engel G., Fenuik W., Fozard J. R., Humphrey P. P. A., Middlemiss D. N., Mylecharane E. J., Richardson B. P., Saxena P. R. Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacol. 1986; 25: 563–576
   PubMed Web of Science ®Google Scholar
• Brittain R. T., Butler A., Coates I. H., Fortune D. H., Hagan R., Hill J. M., Humber D. C., Humphrey P. P. A., Ireland S. J., Jack D., Jordan C. C., Oxford A., Straughan D. W., Tyers M. B. GR38032F, A novel selective 5HT3 receptor antagonist. Br. J. Pharmacol. 1987; 90: 87P
   Google Scholar
• Brown E., Kendall D. A., Nahorski S. R. Inositol phospholipid hydrolysis in rat cerebral cortex slices. I. Receptor characterization. J. Neurochem. 1984; 42: 1379–1387
   PubMedGoogle Scholar
• Bruns C., Marmé D. Pertussis toxin inhibits the angiotensin II and serotonin-induced rise of free cytoplasmic calcium in cultured smooth muscle cells from rat aorta. FEBS Lett. 1987; 212: 40–44
   PubMedGoogle Scholar
• Clarke D. E., Craig D. A., Fozard J. R. The 5-HT4 receptor: naughty but nice. TiPS. 1989; 10: 385–386
   PubMed Web of Science ®Google Scholar
• Clarke W. P., De Vivo M., Beck S. G., Maayani S., Goldfarb J. Serotonin decreases population spike amplitude in hippocampal cells through a pertussis toxin substrate. Brain Res. 1987; 410: 357–361
   PubMedGoogle Scholar
• Claustre Y., Bénavidès J., Scatton B. 5-HT1A receptor agonists inhibit carbachol-induced stimulation of phosphoniositide tumover in the rat hippocampus. Eur. J. Pharmacol 1988; 149: 149–153
   PubMed Web of Science ®Google Scholar
• Conn P. J., Sanders-Bush E. Selective 5 HT antagonists inhibit serotonin stimulated phosphatidylinositol metabolism in cerebral cortex. Neuropharmacol. 1984; 8: 993–996
   Google Scholar
• Conn P. J., Sanders-Bush E. Serotonin stimulated phosphoinositide turnover: mediation by the S2 binding site in rat cerebral cortex but not in subcortical regions. J. Pharmacol. Exp. Ther. 1985; 234: 195–203
   PubMed Web of Science ®Google Scholar
• Conn P. J., Sanders-Bush E. Agonist-induced phosphoinositide hydrolysis in choroid plexus. J. Neurochem. 1986b; 47: 1754–1760
   PubMedGoogle Scholar
• Conn P. J., Sanders-Bush E., Hoffman B. J., Hartig P. R. A unique serotonin receptor in choroid plexus is linked to phosphatidylinositol turnover. Proc. Natl. Acad. Sci. USA 1986; 83: 4086–4088
   PubMed Web of Science ®Google Scholar
• Cory R. N., Berta P., Haiech J., Bockaert J. 5-HT2 receptor-stimulated inositol phosphate formation in rat aortic myocytes. Eur. J. Pharmacol. 1986; 131: 153–157
   PubMedGoogle Scholar
• Costall B., Domeney A. M., Kelly M. E., Naylor R. J., Tyers M. B. The antipsychotic potential of GR38032F, A selective antagonist of 5HT3 receptors in the central nervous system. Br. J. Pharmacol. 1987; 90: 89P
   Google Scholar
• Craig D. A., Clarke D. E. 5-hydroxytryptamine and cholinergic mechanisms in guinea-pig ileum. Br. J. Pharmacol. 1989; 96: 247P
   Google Scholar
• De Chaffoy de Courcelles D., Leysen J. E., De Clerck F., Van Belle H., Janssen P. A.J. Phospholipid turnover is the signal transducing system coupled to serotonin-S2 receptor sites. Biol J. Chem. 1985; 260: 7603–7608
   Google Scholar
• Derkach V., Surprenant A. M., North R. A. 5-HT3 receptors are membrane ion channels. Nature (London) 1989; 339: 706–709
   PubMed Web of Science ®Google Scholar
• De Vivo M., Maayani S. Inhibition of forskolin-stimulated adenylate cyclase activity by 5-HT receptor agonists. Eur. J. Pharmacol. 1989; 119: 231–234
   Google Scholar
• De Vivo M., Maayani S. Characterization of 5-hydroxytryptamine1A-receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea-pig and rat hippocampal membranes. J. Pharmacol. Exp. Ther. 1986; 238: 248–253
   PubMed Web of Science ®Google Scholar
• Doyle V. M., Creba J. A., Rüegg U. T., Hoyer D. Serotonin increases the production of inositol phosphates and mobilises calcium via the 5-HT2 receptor in A7r5 smooth muscle cells. Naunyn-Schmiedeberg's Arch. Pharmacol. 1986; 333: 98–103
   Google Scholar
• Dumuis A., Bouhelal R., Sebben M., Bockaert J. A 5-HT receptor in the central nervous system, positively coupled with adenylate cyclase, is antagonized by ICS 205 930. Eur. J. Pharmacol. 1988; 146: 187–188
   PubMed Web of Science ®Google Scholar
• Dumuis A., Bouhelal R., Sebben M., Cory R., Bockaert J. A non-classical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system. Mol. Pharmacol. 1988; 34: 880–887
   PubMed Web of Science ®Google Scholar
• Engel G., Göthert M., Hoyer D., Schlicker E., Hillenbrand K. Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT1B binding sites. Naunyn-Schmiedeberg's Arch. Pharmacol. 1986; 332: 1–7
   Google Scholar
• Engel G., Hoyer D., Kalkman H. O., Wick M. B. Identification of 5-HT2 receptors on longitudinal muscle of the guinea-pig ileum. J. Rec. Res. 1984; 4: 113–126
   PubMed Web of Science ®Google Scholar
• Fargin A., Raymond J. R., Lohse M. J., Kobilka B. K., Caron M. G., Lefkowitz R. J. The genomic clone G-21 which resembles a β-adrenergic receptor sequence encodes the 5-HT1A receptor. Nature 1988; 335: 358–360
   PubMed Web of Science ®Google Scholar
• Fargin A., Raymond J. R., Regan J. W., Cotecchia S., Lefkowitz R. J., Caron M. G. Effector coupling mechanisms of the cloned 5-HT1A receptor. J. Biol. Chem. 1989; 264: 14848–52
   PubMed Web of Science ®Google Scholar
• Fozard J. R. Differences between receptors for 5-hydroxytryptamine on autonomic neurones revealed by nor-(-)-cocaine. J. Auton. Pharmac. 1983; 3: 21–26
   PubMedGoogle Scholar
• Fozard J. R. MDL 72222, a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 1984; 326: 36–44
   Google Scholar
• Fozard J. R. 5-HT: The Enigma Variations. TIPS. 1987; 8: 501–506
   Web of Science ®Google Scholar
• Fozard J. R. The peripheral effects of 5-Hydroxytryptamine. Oxford University Press, Oxford 1989
   Google Scholar
• Gaddum J. H., Picarelli Z. P. Two kinds of tryptamine receptor. J. Pharmacol. Chemother. 1957; 12: 323–328
   PubMed Web of Science ®Google Scholar
• Gozlan H., El Mestikawy S., Pichat L., Glowinski J., Hamon M. Identification of presynaptic serotonin autoreceptors by a new ligand: 3H-PAT. Nature (London) 1983; 305: 140–142
   PubMed Web of Science ®Google Scholar
• Gozlan H., Schechter L. E., Bolanos F., Emerit M. B., Miquel M. C., Nielsen M., Hamon M. Determination of the molecular size of the 5-HT3 receptor binding site by radiation inactivation. Eur. J. Pharmacol. 1989; 172: 497–500
   PubMedGoogle Scholar
• Hartig P. Molecular biology of 5-HT receptors TIPS 1989; 10: 64–69
   Google Scholar
• Heuring R. E., Peroutka S. J. Characterization of a novel 3H-5-hydroxytryptamine binding site subtype in bovine brain membranes. J. Neurosci. 1987; 7: 894–903
   PubMed Web of Science ®Google Scholar
• Hoyer D. Molecular pharmacology and biology of 5-HT1C receptors. TIPS 1988; 9: 89–94
   PubMed Web of Science ®Google Scholar
• Hoyer D. Functional correlates of serotonin 5-HT1 recognition sites. J. Rec. Res. 1988; 8: 59–81
   PubMed Web of Science ®Google Scholar
• Hoyer D. Biochemical mechanisms of 5-HT receptor-effector coupling in peripheral tissues. The peripheral actions of 5-hydroxytryptamine, J. R. Fozard. Oxford University Press. 1989; 72–99
   Google Scholar
• Hoyer D. 5-HT3 5-HT4 and 5-HT-M receptors. Neuropsychopharmacology. 1990, in press
   Google Scholar
• Hoyer D., Engel G., Kalkman H. O. Characterization of the 5-HT1B recognition site in rat brain: binding studies with [125I]iodocyanopindolol. Eur. J. Pharmacol. 1985; 118: 1–12
   PubMedGoogle Scholar
• Hoyer D., Engel G., Kalkman H. O. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin. Eur. J. Pharmacol. 1985; 118: 13–23
   PubMed Web of Science ®Google Scholar
• Hoyer D., Middlemiss D. N. The pharmacology of the terminal 5-HT autoreceptors in mammalian brain: evidence for species differences. Trends Pharmacol. Sci. 1989; 10: 130–132
   PubMed Web of Science ®Google Scholar
• Hoyer D., Neijt H. C. Identification of serotonin 5-HT3 recognition sites by radioligand binding in NG 108–15 neuroblastoma-glioma cells. Eur. J. Pharmacol. 1987; 143: 191–192
   Google Scholar
• Hoyer D., Neijt H. C. Identification of serotonin 5-HT3 recognition sites in membranes of N1E-115 neuroblastoma cells by radioligand binding. Mol. Pharmacol. 1988; 33: 303–309
   PubMedGoogle Scholar
• Hoyer D., Pazos A., Probst A., Palacios J. M. Serotonin receptors in the human brain, I: Characterization and autoradiographic localization of 5-HT1A recognition sites. Apparent absence of 5-HT1B recognition sites. Brain Res. 1986; 376: 85–96
   PubMed Web of Science ®Google Scholar
• Hoyer D., Schoeffter P. 5-HT1D receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in calf substantia nigra. Eur. J. Pharmacol. 1988; 147: 145–147
   PubMedGoogle Scholar
• Hoyer D., Schoeffter P., Waeber C., Palacios J. M., Dravid A. 5-HT1C receptor-mediated stimulation of inositol phosphate production in pig choroid plexus; a pharmacological characterization. Naunyn Schmiedeberg's Arch. Pharmacol. 1989; 339: 252–258
   Google Scholar
• Julius D., MacDermott A. B., Axel R., Jessell T. M. Molecular characterization of a functional cDNA encoding the serotonin 1c receptor. Science 1988; 241: 558–564
   PubMed Web of Science ®Google Scholar
• Kennett G. A., Curzon G. Evidence that hypophagia induced by mCPP and TFMPP requires 5-HT1C and 5-HT1B receptors; hypophagia induced by RU 24969 only requires 5-HT1B receptors. Psychopharmacol. 1988; 96: 93–100
   PubMed Web of Science ®Google Scholar
• Kennett G. A., Curzon G. Evidence that mCPP may have behiavioural effects mediated by central 5-HT1C receptors. Br. J. Pharmacol. 1988; 94: 137–147
   PubMed Web of Science ®Google Scholar
• Kilpatrick G. J., Jones B. J., Tyers M. B. The identification and distribution of 5-HT3 receptors in rat brain using radioligand binding. Nature 1987; 330: 746–748
   PubMed Web of Science ®Google Scholar
• Leysen J. E., Niemegeers C. J. E., Van Nueten J. M., Laduron P. M. [3H]ketanserin (R41 468), a selective 3H ligand for serotonin 2 receptor binding sites. Mol. Pharmacol. 1982; 21: 301–314
   PubMed Web of Science ®Google Scholar
• Markstein R., Hoyer D., Engel G. 5HT1A-receptors mediate stimulation of adenylate cyclase in rat hippocampus. Naunyn-Schmiedeberg's Arch. Pharmacol. 1986; 333: 335–341
   Google Scholar
• Molderings G. J., Fink K., Schlicker E., Göthert M. Inhibition of noradrenaline release in the rat vena cava via presynaptic 5-HT1B receptors. Naunyn Schmiedeberg's Arch. Pharmacol. 1987; 336: 245–250
   Google Scholar
• Murphy T. J., Bylund D. B. Oxymetazoline inhibits adenylate cyclase by activation of serotonin-1 receptors in the OK cell, an established renal epithelial cell line. Mol. Pharmacol. 1988; 34: 1–7
   PubMedGoogle Scholar
• Nakaki T., Roth B. L., Chuang D., Costa E. Phasic and tonic components in 5-HT2 receptor-mediated rat aorta contraction: participation of Ca++ channels and phospholipase C. J. Pharmacol. Exp. Ther. 1985; 234: 442–446
   PubMedGoogle Scholar
• Neijt H. C., te Duits I. J., Vijverberg H. P.M. Pharmacological characterization of serotonin 5-HT3 receptor-mediated electrical response in cultured mouse neuroblastoma cells. Neuropharmacol. 1988; 27: 301–307
   PubMedGoogle Scholar
• Osborne N. N., Hamon M. Neuronal Serotonin. John Wiley and Sons. 1988; 555
   Google Scholar
• Pazos A., Hoyer D., Palacios J. M. The binding of serotonergic ligand to the porcine choroid plexus: characterization of a new type of serotonin recognition site. Eur. J. Pharmacol. 1984; 106: 539–546
   PubMed Web of Science ®Google Scholar
• Pazos A., Palacios J. M. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors. Brain Res. 1988; 346: 205–230
   Google Scholar
• Peroutka S. J. 5-Hydroxytryptamine receptor subtypes. Ann. Rev. Neurosci. 1988; 11: 45–60
   PubMed Web of Science ®Google Scholar
• Peroutka S. J., Hamik A. [3H]Quipazine labels 5-HT3 recognition sites in rat cortical membranes. Eur. J. Pharmacol. 1988; 148: 297–299
   PubMedGoogle Scholar
• Peroutka S. J., Snyder S. H. Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol. Mol. Pharmacol. 1979; 16: 687–699
   PubMed Web of Science ®Google Scholar
• Peroutka S. J., Hamik A., Harrington M. A., Hoffman A. J., Mathis C. A., Pierce P. A., Wang S. S.H. (R)-(-)-[77Br]4-bromo-2,5-dimethoxyamphetamine labels a novel 5-hydroxytryptamine binding site in brain membranes. Mol. Pharmacol. 1988; 34: 537–542
   PubMed Web of Science ®Google Scholar
• Peters J. A., Lambert J. L. Electrophysiology of 5-HT3 receptors in neuronal cell lines. TIPS 1989; 10: 172–175
   PubMed Web of Science ®Google Scholar
• Pritchett D. B., Bach A. W. J., Wozny M., Taleb O., Dal Toso R., Shih J. C., Seeburg P. H. Structure and functional expression of cloned rat serotonin 5-HT2 receptor. EMBO J. 1988; 7: 4135–4140
   PubMed Web of Science ®Google Scholar
• Richardson B. P., Engel G. The pharmacology and function of the 5-HT₃ receptors Trends Neurosci. 1986; 9: 424–428
   Web of Science ®Google Scholar
• Richardson B. P., Engel G., Donatsch P., Stadler P. A. Identification of serotonin M receptor subtypes and their specific blockade by a new class of drugs. Nature (London) 1985; 316: 126–131
   PubMed Web of Science ®Google Scholar
• Roth B. L., Nakaki T., Chuang D.-M., Costa E. Aortic recognition sites for serotonin (5-HT) are coupled to phospholipase C and modulate phosphatidylinositol turnover. Neuropharmacol. 1984; 23: 1223–1225
   PubMed Web of Science ®Google Scholar
• Sanders-Bush E. The Serotonin Receptors. Humana Press. 1989; 388
   Google Scholar
• Sanger G. J. Increased gut cholinergic activity and antagonism of 5-hydroxytryptamine M-receptors by BRL 24924: potential clinical importance of BRL 24924. Br. J. Pharmacol. 1987; 91: 77–87
   PubMed Web of Science ®Google Scholar
• Schlicker E., Fink K., Göthert M., Hoyer D., Molderings G., Roschke I., Schoeffter P. The pharmacological properties of the presynaptic 5-HT autoreceptor in the pig brain cortex conform to the 5-HT10 receptor subtype. Naunyn-Schmiedeberg's Arch. Pharmacol. 1989; 340: 45–51
   Google Scholar
• Schoeffter P., Hoyer D. Centrally acting hypotensive agents with affinity for 5-HT1A binding sites inhibit forskolin-stimulated adenylate cyclase activity in calf hippocampus. Br. J. Pharmacol. 1988; 95: 975–985
   PubMedGoogle Scholar
• Schoeffter P., Hoyer D. 5-Hydroxytryptamine 5HT1B and 5-HT1D receptors mediating inhibition of adenylate cyclase activity. Pharmacological comparison with special reference to the effects of yohimbine, rauwolscine and some β-adrenoceptor antagonists. Naunyn-Schmiedeberg's Arch. Pharmacol. 1989; 340: 285–292
   Google Scholar
• Schoeffter P., Hoyer D. 5-hydroxytryptamine (5-HT) induced endothelium-dependent relaxation of pig coronary arteries is mediated by 5-HT receptors similar to the 5-HT1D receptor subtype. J. Pharmacol. Exp. Therap. 1990; 252: 387–395
   PubMed Web of Science ®Google Scholar
• Schoeffter P., Waeber C., Palacios J. M., Hoyer D. The serotonin 5-HT1D receptor subtype is negatively coupled to adenylate cyclase in calf substantia nigra. Naunyn Schmledeberg's Arch. Pharmacol. 1988; 337: 602–608
   Google Scholar
• Seuwen K., Magnaldo I., Pouysségur J. Serotonin stimulates DNA synthesis in fibroblasts acting through 5-HT1B receptors coupled to a Gi-protein. Nature 1988; 335: 254–256
   PubMed Web of Science ®Google Scholar
• Shenker A., Maayani S., Weinstein H., Green J. P. Enhanced serotonin-stimulated adenylate cyclase activity in membranes from adult guinea-pig hippocampus. Life Sci. 1983; 32: 2335–2342
   PubMedGoogle Scholar
• Shenker A., Maayani S., Weinstein H., Green J. P. Two 5-HT receptors linked to adenylate cyclase in guinea pig hippocampus are descriminated by 5-carboxamidotryptamine and spiperone. Eur. J. Pharmacol. 1985; 109: 427–429
   PubMedGoogle Scholar
• Shenker A., Maayani S., Weinstein H., Green J. P. Pharmacological characterization of two 5-hydroxtryptamine receptors coupled to adenylate cyclase in guinea pig hippocampal membranes. Mol. Pharmacol. 1987; 31: 357–367
   PubMedGoogle Scholar
• Waeber C., Dietl M. M., Hoyer D., Probst A., Palacios J. M. Visualization of a novel serotonin recognition site (5-HT1D) in the human brain by autoradiography. Neurosci. Lett. 1988; 88: 11–16
   PubMedGoogle Scholar
• Waeber C., Dietl M. M., Hoyer D., Palacios J. M. 5-HT1 receptors in the vertebrate brain: regional distribution examined by autoradiography. Naunyn Schmiedeberg's Arch. Pharmacol. 1989; 340: 486–494
   Google Scholar
• Waeber C., Dixon K., Hoyer D., Falacios J. M. Localization by autoradiography of neuronal 5-HT3receptors in mouse CNS. Eur. J. Pharmacol. 1988; 151: 351–352
   PubMedGoogle Scholar
• Waeber C., Schoeffter P., Palacios J. M., Hoyer D. Molecular pharmacology of 5-HT1D recognition sites: radioligand binding studies in human, pig and calf brain membranes. Naunyn Schmiedeberg's Arch. Pharmacol. 1988; 337: 595–601
   Google Scholar
• Waeber C., Schoeffter P., Palacios J. M., Hoyer D. 5-HT1D receptors in the guinea-pig and pigeon brain: radioligand binding and biochemical studies. Naunyn-Schmiedeberg's Arch. Pharmacol. 1989; 340: 479–485
   Google Scholar
• Watling K. J., Aspley S., Swain C. J., Saunders J. [3H]-Quaternised ICS 205–930 labels 5-HT3 receptor binding sites in rat brain. Eur. J. Pharmacol. 1988; 149: 397–398
   PubMedGoogle Scholar
• Weiss S., Sebben M., Kemp D. E., Bockaert J. Serotonin 5-HT1 receptors mediate inhibition of cyclic AMP production in neurons. Eur. J. Pharmacol. 1986; 120: 227–230
   PubMed Web of Science ®Google Scholar
• Yakel J. L., Jackson M. B. 5-HT3 receptors mediate rapid responses in cultured hippocampus and a clonal cell line. Neuron. 1988; 1: 615–621
   PubMed Web of Science ®Google Scholar